Skip to main content
. 2018 Jun 5;32:125–133. doi: 10.1016/j.ebiom.2018.05.030

Fig. 3.

Fig. 3

Treatment-free survival according to dichotomized metabolic score (D-MS). Analysis of all CLL patients (HR n = 45, LR n = 51; A), as well as subgroups that are TP53 deleted or mutated (HR n = 8, LR n = 10; B), with del11q22–23 (HR n = 8, LR n = 6; C), IGHV-M (HR n = 17, LR n = 22; D) and IGHV-U (HR n = 18, LR n = 16; E).